association of csf and plasma biomarkers with longitudinal tau accumulation
Published 2 years ago • 85 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
36:39
multiplex immunoassay detection of alzheimer's disease biomarker
-
1:32
investigating novel plasma-based p-tau biomarkers
-
1:23
csf tau as a biomarker of therapeutic effect
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
1:14
what do we understand about the secretion of brain p-tau in ad?
-
37:19
diagnosis of alzheimer's disease by imaging of amyloid and tau positron emission tomography_20230906
-
3:27
cerebrospinal fluid (csf) explained in 3 minutes - function, composition, circulation
-
11:28
targeting tau in alzheimer's disease
-
1:06
cerebrospinal fluid (csf) and imaging biomarkers for the differential diagnosis of dementia
-
5:19
examining plasma vs. csf p-tau217 in preclinical and prodromal alzheimer’s disease
-
2:26
the use of csf biomarkers in the diagnosis of alzheimer's disease
-
6:06
[research] csf correlates of neuropsychiatric symptoms in patients with alzheimer disease (ad)
-
18:36
development and validation of cerebrospinal fluid & blood biomarkers for neurodegenerative diseases
-
4:32
plasma tau217 occupancy as accurate as validated csf tests
-
15:23
alzheimer's disease csf biomarkers
-
2:19
early predictive value of plasma biomarkers for amyloid positivity
-
2:57
the potential of plasma biomarkers in dementia
-
1:14
plasma tau levels and alzheimer’s disease: what’s the relationship?
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
10:12
predicting amyloid pet and tau pet stages with plasma biomarkers
-
2:25
astrocyte biomarkers associated with amyloid-β and tau pathologies
-
2:21
strem2 in csf associates with amyloid, tau, and cognition in autosomal-dominant alzheimer's disease